SynthesisEuropean journal of clinical pharmacology2026
A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.
Weifeng Shao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.